J. Millar

发表

Caregivers’ information needs and their ‘experiences of care’ during treatment are associated with elevated anxiety and depression: a cross-sectional study of the caregivers of renal cancer survivors

G. Giles, M. Jefford, I. Davis, 2016, Supportive Care in Cancer.

In vivo characterization and numerical simulation of prostate properties for non‐thermal irreversible electroporation ablation

Helen Kavnoudias, Kenneth R Thomson, Rafael V Davalos, 2014, The Prostate.

Activation of hip prostheses in high energy radiotherapy and resultant dose to nearby tissue

Michael L. Taylor, Ryan L. Smith, T. Kron, 2017, Journal of applied clinical medical physics.

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial.

M. Parmar, M. Sydes, D. Dearnaley, 2007, The Lancet. Oncology.

Comparison of IPSA and HIPO inverse planning optimization algorithms for prostate HDR brachytherapy

Vanessa Panettieri, Ryan L. Smith, J. Millar, 2014, Journal of applied clinical medical physics.

Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group.

Jeremy L Millar, Thomas P Shakespeare, A. Kneebone, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy

J. Millar, M. Ebert, A. Haworth, 2018, Physics in medicine and biology.

A double exposed portal image comparison between electronic portal imaging hard copies and port films in radiation therapy treatment setup confirmation to determine its clinical application in a radiotherapy center.

A. Rodger, J. Millar, M. J. Dally, 2001, International journal of radiation oncology, biology, physics.

Changing pattern of radiation therapy for bone metastases in an Australian population-based cohort of men with prostate cancer.

R. Milne, J. Millar, F. Foroudi, 2021, Clinical genitourinary cancer.

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost

D. Joseph, J. Millar, T. Rancati, 2020, Frontiers in Oncology.

Practical considerations in the selection of seed strength for prostate implants

J. Millar, S. L. Elliott, C. Beaufort, 2015, Journal of applied clinical medical physics.

Brachytherapy‐based radiotherapy with androgen deprivation for management of high‐risk prostate cancer – time to reverse the declining trend?

J. Yaxley, J. Millar, W. Ong, 2018, BJU international.

Body size and dietary risk factors for aggressive prostate cancer: a case–control study

D. English, G. Giles, G. Severi, 2019, Cancer Causes & Control.

Blindness in patients after external beam irradiation for pituitary adenomas: two cases occurring after small daily fractional doses.

N. Spry, J. Millar, D. Lamb, 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).

Distress and unmet needs during treatment and quality of life in early cancer survivorship: A longitudinal study of haematological cancer patients

G. Giles, V. White, M. Jefford, 2017, European journal of haematology.

The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period

G. Giles, V. White, M. Jefford, 2017, Journal of Cancer Survivorship.

The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2015, BJU international.

Long-Term Outcomes of Patients with Localized Rectal Cancer Treated with Chemoradiation or Radiotherapy Alone Because of Medical Inoperability or Patient Refusal

P. Gibbs, D. Kipp, J. Millar, 2007, Diseases of the colon and rectum.

Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma.

U. Schneider, J. Millar, Jarad Martin, 2008, International journal of radiation oncology, biology, physics.

Contemporary management of renal cell carcinoma (RCC) in Victoria: implications for longer term outcomes and costs

G. Giles, M. Coory, V. White, 2013, BJU international.

The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs

P. Choyke, G. Jenster, B. Tombal, 2020, Nature Reviews Urology.

Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management

C. Higano, C. Moore, A. Richardson, 2018, The Journal of urology.

A whole of population‐based series of radical prostatectomy in Victoria, 1995 to 2000

G. Giles, G. Severi, Charmaine D. Smith, 2009, Australian and New Zealand journal of public health.

Disease‐specific quality of life among patients with localized prostate cancer: an Australian perspective

M. Frydenberg, Fiona J. Newton, J. Millar, 2006, BJU international.

Increased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms—A whole of population study

G. Giles, N. Lawrentschuk, D. Bolton, 2015, Prostate international.

Total and beverage-specific alcohol intake and the risk of aggressive prostate cancer: a case–control study

D. English, G. Giles, G. Severi, 2017, Prostate Cancer and Prostatic Diseases.

A patient-centred approach to determine optimal supportive care across the cancer trajectory: a cross-sectional study.

R. Sanson-Fisher, Rochelle Watson, H. Turon, 2021, European journal of cancer care.

Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population‐based cohort of men with intermediate‐ and high‐risk prostate cancer

J. Millar, F. Foroudi, S. Evans, 2017, BJU international.

Quality of care achievements of the Prostate Cancer Outcomes Registry–Victoria

D. Murphy, M. Frydenberg, I. Davis, 2016, The Medical journal of Australia.

(Dis)concordance of comorbidity data and cancer status across administrative datasets, medical charts, and self-reports

G. Tikellis, J. Millar, M. Evans, 2020, BMC Health Services Research.

The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment

G. Giles, R. Milne, V. White, 2019, Cancers.

Establishing metastatic prostate cancer quality indicators using a modified Delphi approach.

M. Fitch, I. Davis, F. Pouliot, 2022, Clinical genitourinary cancer.

Patterns of primary staging for newly diagnosed prostate cancer in the era of prostate specific membrane antigen positron emission tomography: A population‐based analysis

N. Lawrentschuk, D. Murphy, D. Bolton, 2021, Journal of medical imaging and radiation oncology.

Predictors of prostate cancer specific mortality after radical prostatectomy: 10 year oncologic outcomes from the Victorian Radical Prostatectomy Registry

G. Giles, D. Bolton, J. Millar, 2015, BJU international.

Active surveillance of men with low risk prostate cancer: evidence from the Prostate Cancer Outcomes Registry–Victoria

D. Murphy, M. Frydenberg, A. Earnest, 2018, The Medical journal of Australia.

The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy‐related infection over 5 years

A. Cheng, J. Millar, A. C. Cheng, 2015, BJU international.

An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk.

T. Pickles, J. Millar, S. Turner, 2006, International journal of radiation oncology, biology, physics.

Development of Indicators to Assess Quality of Care for Prostate Cancer.

David P. Smith, D. Roder, M. Frydenberg, 2016, European urology focus.

What to do for prostate cancer patients with a rising PSA?--A survey of Australian practice.

J. Millar, P. Royce, M. Rosenthal, 2003, International journal of radiation oncology, biology, physics.

Large variation in radiation therapy fractionation for multiple myeloma in Australia

R. Milne, M. MacManus, J. Millar, 2022, Asia-Pacific journal of clinical oncology.

Evolving Practice Pattern of Palliative Radiation Therapy for Bone Metastases from Lung Cancer in Australia.

D. Ball, J. Millar, F. Foroudi, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the esophagus

V. Gebski, P. Devitt, D. Joseph, 2002 .

Adjuvant radiotherapy for DCIS

A. Rodger, J. Millar, 2000, The Lancet.

Re: Finney G, Haynes A-M, Cross P, et al: Cross-sectional analysis of sexual function after prostate brachytherapy (Urology 66: 377-381, 2005).

J. Millar, 2008, Urology.

Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare Standards

J. Wale, J. Zalcberg, D. Currow, 2021, The Medical journal of Australia.

Is radiotherapy a good adjuvant strategy for men with a history of cryptorchism and stage I seminoma?

J. Millar, Jarad Martin, M. Fay, 2010, International journal of radiation oncology, biology, physics.

Surgery for oesophageal squamous cell carcinoma

J. Millar, 1994, The Lancet.

Effect of prostate-specific antigen bounce on outcome in patients treated with permanent 125I-seed prostate brachytherapy

Ryan L. Smith, J. Millar, N. Andrianopoulos, 2009 .

Cancer Treatment Patterns and Factors Affecting Receipt of Treatment in Older Adults: Results from the ASPREE Cancer Treatment Substudy (ACTS)

Suzanne G. Orchard, P. Gibbs, R. Woods, 2022, medRxiv.

How Prostate Cancer Patients are Surveyed may Influence Self-Reported Sexual Function Responses.

J. Millar, N. Papa, M. Perera, 2022, The journal of sexual medicine.

Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New Zealand

L. FitzGerald, A. Hayden, J. Millar, 2021, JAMA network open.

Choosing Wisely in radiation therapy for breast cancer: Time lag in adoption of hypofractionated radiation therapy in Victoria

R. Milne, J. Millar, F. Foroudi, 2021, Journal of medical imaging and radiation oncology.

A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP “RAVES” Trial

R. Fisher, H. Woo, M. Frydenberg, 2019, International Journal of Radiation Oncology*Biology*Physics.

Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer

J. Tjandra, J. Pedersen, J. Millar, 2001, Diseases of the colon and rectum.

In regard to Pollack et al., prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. IJROBP 2002;53:1097-1105.

J. Millar, Scott G. Williams, 2003, International journal of radiation oncology, biology, physics.

Human immunodeficiency virus–related primary central nervous system lymphoma

B. Brew, J. Millar, A. Grulich, 2004, Cancer.

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.

R. Fisher, H. Woo, M. Frydenberg, 2020, The Lancet Oncology.

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

V. Gebski, R. Simes, R. Simes, 2005, The Lancet. Oncology.

A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease

Suzanne G. Orchard, P. Gibbs, J. McNeil, 2021, Cancers.

Accrediting radiation technique in a multicentre trial of chemoradiation for pancreatic cancer

J. Harvey, A. Kneebone, N. Spry, 2008, Journal of medical imaging and radiation oncology.

3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome.

D. Goldstein, B. Iacopetta, A. Kneebone, 2008, International journal of radiation oncology, biology, physics.

Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials

Ryan L. Smith, M. Stockler, G. Pond, 2018, International Journal of Radiation Oncology*Biology*Physics.

Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.

M. Stockler, H. Woo, R. Milne, 2016, The Lancet. Oncology.

M. Stockler, H. Woo, M. King, 2017, The Lancet. Oncology.

Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial

Patrick J Owen, J. Millar, R. Daly, 2017, Trials.

Androgen suppression plus radiation for prostate cancer.

J. Millar, 2004, JAMA.

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.

M. Parmar, M. Sydes, D. Dearnaley, 2014, The Lancet. Oncology.

High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer.

J. Millar, N. Andrianopoulos, G. Duchesne, 2010, Brachytherapy.

Contemporary practice patterns of stereotactic radiosurgery for brain metastasis: A review of published Australian literature

J. Ruben, J. Millar, F. Foroudi, 2019, Journal of medical imaging and radiation oncology.

Self‐reported lack of energy or feeling depressed 12 months after treatment in men diagnosed with prostate cancer within a population‐based registry

N. Lawrentschuk, D. Murphy, M. Frydenberg, 2021, Psycho-oncology.

Predictors and rate of adjuvant radiation therapy following radical prostatectomy: A report from the Prostate Cancer Registry

J. Millar, T. Spelman, S. Sengupta, 2016, Journal of medical imaging and radiation oncology.

Prostate-specific antigen bounce after permanent iodine-125 prostate brachytherapy--an Australian analysis.

J. Millar, N. Andrianopoulos, P. Royce, 2011, International journal of radiation oncology, biology, physics.

HIV and renal cell carcinoma: Experience in an Australian statewide HIV center

J. Millar, P. Royce, J. Hoy, 2016, Asia-Pacific journal of clinical oncology.

Clinicopathological characteristics and management of prostate cancer in the human immunodeficiency virus (HIV)‐positive population: experience in an Australian major HIV centre

J. Millar, P. Royce, W. Ong, 2015, BJU international.

Transition Points for the Routine Integration of Palliative Care in Patients With Advanced Cancer.

V. Sundararajan, L. Mileshkin, M. Krishnasamy, 2018, Journal of pain and symptom management.

Monitoring Quality of Care in Men Diagnosed with Prostate Cancer: Developing Consensus Quality Indicators Using Modified-Delphi Methodology

D. Murphy, Joanne Dean, J. Millar, 2015 .

Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry

A. Costello, D. Murphy, M. Frydenberg, 2014, BJU international.

A randomised, double‐blind, placebo‐controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer

J. Millar, G. Duchesne, B. Hindson, 2013, Journal of medical imaging and radiation oncology.

Arteriovenous malformations of the brain: outcome of conventional radiotherapy in the management of 33 cases.

N. Spry, J. Millar, D. Lamb, 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).

Alternative explanations for T-cell response to in-situ gene therapy for prostate cancer: in reply to Fujita et al. (Int J Radiat Oncol Biol Phys 2006;65:84-90).

J. Millar, J. Sutherland, R. Boyd, 2006, International journal of radiation oncology, biology, physics.

The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers

G. Giles, V. White, M. Jefford, 2017, Supportive Care in Cancer.

A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy – Adjuvant Versus Early Salvage (RAVES) trial

R. Fisher, H. Woo, M. Frydenberg, 2014, BJU international.

Variation in the use of single- versus multi-fractions palliative radiotherapy for bone metastases in Australia.

R. Milne, J. Millar, F. Foroudi, 2019, International journal of radiation oncology, biology, physics.

Variation in the Use of Single- Versus Multifraction Palliative Radiation Therapy for Bone Metastases in Australia

R. Milne, J. Millar, F. Foroudi, 2022 .

Trend in stereotactic radiation therapy use for management of bone and brain metastases in patients with renal cell carcinoma in Australia.

R. Milne, S. Siva, J. Millar, 2021, The oncologist.

Low uptake of upfront autologous transplantation for myeloma in a jurisdiction with universal health care coverage: a population-based patterns of care study in Australia.

G. Giles, M. Coory, V. White, 2014, Clinical lymphoma, myeloma & leukemia.

Trends in the surgical management of stage 1 renal cell carcinoma: findings from a population‐based study

David J. T. Marco, M. Coory, V. White, 2017, BJU international.

Trial Localized Prostate Cancer: A Randomized Controlled vs Radiation Therapy Alone for Patients With Clinically 6-Month Androgen Suppression Plus Radiation Therapy

J. Manola, A. D'Amico, T. DeWeese, 2010 .

Long-term erectile function following permanent seed brachytherapy treatment for localized prostate cancer.

P. Pharoah, J. Millar, W. Ong, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer.

U. Schneider, J. Ruben, J. Millar, 2009, International journal of radiation oncology, biology, physics.

‘GAP’ in radiotherapy services in Australia and New Zealand in 2009

J. Millar, M. Barton, N. Gogna, 2010, Journal of medical imaging and radiation oncology.

Disparities in radiation therapy utilization for cancer patients in Victoria

R. Milne, H. Elsaleh, G. Hanna, 2022, Journal of medical imaging and radiation oncology.

15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience.

Robert W Galbreath, Jeremy Millar, J. Blasko, 2007, International journal of radiation oncology, biology, physics.

Prostate 15-YEAR BIOCHEMICAL RELAPSE FREE SURVIVAL IN CLINICAL STAGE T 1T 3 PROSTATE CANCER FOLLOWING COMBINED EXTERNAL BEAM RADIOTHERAPY AND BRACHYTHERAPY ; SEATTLE EXPERIENCE

J. Blasko, J. Sylvester, P. Grimm, 2006 .

Are We Choosing Wisely in Radiation Oncology Practice-Findings From an Australian Population-Based Study.

R. Milne, J. Millar, F. Foroudi, 2019, International journal of radiation oncology, biology, physics.

Variations in whole brain radiation therapy fractionation for brain metastases in Victoria

R. Milne, J. Millar, F. Foroudi, 2022, Journal of medical imaging and radiation oncology.

Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016.

R. Milne, J. Millar, F. Foroudi, 2019, European urology oncology.

Predictors of real‐world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone‐sensitive prostate cancer

D. Murphy, B. Tran, I. Davis, 2021, Internal medicine journal.

Australian & New Zealand Faculty of Radiation Oncology Genito‐Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder

A. Kneebone, J. Millar, F. Foroudi, 2012, Journal of medical imaging and radiation oncology.

Systematic review of quality improvement interventions directed at cancer specialists.

G. Giles, M. Coory, V. White, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer.

J. Millar, G. Duchesne, G. Pratt, 2004, International journal of radiation oncology, biology, physics.

Long‐term outcomes following post‐operative radiotherapy for Stage I/II testicular seminoma – an Australasian single‐institution experience

J. Millar, W. Ong, B. Hindson, 2016, Journal of medical radiation sciences.

Optimal Treatment for High-Risk Prostate Cancer.

J. Millar, W. Ong, T. Koh, 2018, JAMA.

Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

Adam P Dicker, Richard Stock, Steven Frank, 2012, BJU international.

A Whole of Population, Multiuser Series of High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: Outcomes and Implications.

H. Woo, G. Giles, G. Severi, 2015, Journal of endourology.

Comparison of urinary and sexual patient-reported outcomes between open radical prostatectomy and robot-assisted radical prostatectomy: a propensity score matched, population-based study in Victoria

A. Forbes, J. Millar, S. Evans, 2022, BMC Urology.

Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone.

J. Millar, B. Matheson, Aaron R. Kent, 2019, Brachytherapy.

Cohort profile: the TrueNTH Global Registry - an international registry to monitor and improve localised prostate cancer health outcomes

H. Huland, C. Moore, M. Litwin, 2017, BMJ Open.

Late, persistent, substantial treatment-related symptoms (LAPERS) following low-dose-rate brachytherapy for prostate cancer.

J. Millar, W. Ong, 2022, Brachytherapy.

Decline in acute urinary toxicities with increased institutional experience: 15-year experience of permanent seed prostate brachytherapy in a single Australasian institution.

J. Millar, W. Ong, B. Matheson, 2017, Brachytherapy.

Radiation oncology trainee research requirements – re‐thinking our intention and approach

D. Ball, J. Millar, F. Foroudi, 2020, Journal of medical imaging and radiation oncology.

Understanding the Relationship Between Interactive Optimisation and Visual Analytics in the Context of Prostate Brachytherapy

Jie Liu, Annette Haworth, Kim Marriott, 2018, IEEE Transactions on Visualization and Computer Graphics.

Under‐utilisation of high‐dose‐rate brachytherapy boost in men with intermediate‐high risk prostate cancer treated with external beam radiotherapy

J. Millar, S. Evans, W. Ong, 2018, Journal of medical imaging and radiation oncology.

Androgen deprivation therapy use with post‐prostatectomy radiotherapy in the Prostate Cancer Outcomes Registry Victoria

J. Millar, F. Foroudi, S. Evans, 2018, Journal of medical imaging and radiation oncology.

Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011

A. Costello, D. Murphy, M. Frydenberg, 2013, The Medical journal of Australia.

Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors.

J. Millar, B. Hindson, B. Matheson, 2013, Brachytherapy.

Comparison of oncological and health‐related quality of life outcomes between open and robot‐assisted radical prostatectomy for localised prostate cancer – findings from the population‐based Victorian Prostate Cancer Registry

D. Murphy, J. Millar, T. Spelman, 2016, BJU international.

Clinical Application of Pre-Treatment Image Verification of Catheter Positions for HDR Prostate Brachytherapy

Ryan L. Smith, J. Millar, R. Franich, 2017 .

Patterns of care and outcomes for men diagnosed with prostate cancer in Victoria: an update

D. Murphy, A. Earnest, J. Millar, 2018, ANZ journal of surgery.

Prevalence of Baseline Erectile Dysfunction (ED) in an Australian Cohort of Men with Localized Prostate Cancer.

J. Millar, W. Ong, Hamish McLachlan, 2015, The journal of sexual medicine.

What defines intermediate-risk prostate cancer? Variability in published prognostic models.

J. Millar, G. Duchesne, M. Dally, 2004, International journal of radiation oncology, biology, physics.

The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer

G. Giles, M. Frydenberg, D. Bolton, 2013, BJU international.

Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method.

H. Elsaleh, J. Millar, B. Higgs, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A biochemical definition of cure after brachytherapy for prostate cancer.

G. Merrick, W. J. Morris, J. Ciezki, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Source position verification and dosimetry in HDR brachytherapy using an EPID.

A Haworth, R D Franich, L. McDermott, 2013, Medical physics.

Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study

Damien Bolton, Nathan Lawrentschuk, Graham G. Giles, 2017, Cancer Causes & Control.

Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control study.

D. English, G. Giles, G. Severi, 2017, Urologic oncology.

Establishing a global quality of care benchmark report

J. Gore, A. Vickers, A. Finelli, 2021, Health informatics journal.

Men’s perceptions of prostate cancer diagnosis and care: insights from qualitative interviews in Victoria, Australia

K. Young, J. Fisher, M. Kirkman, 2017, BMC Cancer.

Comparison of Patient-Reported Quality-of-Life and Complications in Men With Prostate Cancer, Between Two Modes of Administration.

R. Ruseckaite, J. Millar, S. Evans, 2016, Clinical genitourinary cancer.

Managing HIV. Part 5: Treating secondary outcomes. 5.14 HIV and Kaposi's sarcoma.

K. Gelmon, D. Goldstein, J. Millar, 1996, Medical Journal of Australia.

InvivoCharacterization andNumerical Simulationof Prostate Properties forNon-Thermal Irreversible ElectroporationAblation

R. E. Neal, Ryan L. Smith, R. Davalos, 2014 .

MANAGEMENT OF SUPERFICIAL BLADDER CANCER IN VICTORIA: 1990 AND 1995

M. Frydenberg, D. Bolton, J. Millar, 2005, ANZ journal of surgery.

Rectal cancer in Victoria in 1994: Patterns of reported management

S. Lade, J. Zalcberg, J. Millar, 2002, ANZ journal of surgery.

Prostate cancer in Victoria in 1993: patterns of reported management

G. Giles, M. Frydenberg, H. Mameghan, 2000, The Medical journal of Australia.

TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol

P. Keall, Joanne M. Smart, C. Oldmeadow, 2019, BMJ Open.

A Randomized Controlled Trial of an Additional Funding Intervention to Improve Clinical Trial Enrollment.

M. Jefford, D. Dilts, R. Wolfe, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy.

Jeremy L Millar, J. Millar, Scott G Williams, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patterns of end-of-life hospital care for patients with non-Hodgkin lymphoma: exploring the landscape

V. Sundararajan, M. Krishnasamy, J. Millar, 2019, Leukemia & lymphoma.

A simple technique for determining accurate urethral dosimetry after seed brachytherapy for prostate cancer.

J. Millar, Angelene Z Longano, Samantha J Imbert, 2006, Brachytherapy.

The trajectory of patients who die from metastatic prostate cancer: a population‐based study

V. Sundararajan, L. Mileshkin, M. Krishnasamy, 2018, BJU international.

Development of Technologic Solutions to Address Complex Local Requirements of an International Prostate Cancer Clinical Quality Registry.

Mark Lucas, Hartwig Huland, Sue M Evans, 2019, JCO clinical cancer informatics.

Diagnostic and treatment factors associated with poor survival from prostate cancer are differentially distributed between regional and metropolitan Victoria, Australia

M. Frydenberg, R. Ruseckaite, J. Millar, 2016, BMC Urology.

An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging.

Annette Haworth, Vanessa Panettieri, Jeremy L Millar, 2017, Brachytherapy.

3D catheter reconstruction in HDR prostate brachytherapy for pre-treatment verification using a flat panel detector.

Annette Haworth, Vanessa Panettieri, Jeremy L Millar, 2017, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Are we over-diagnosing and over-treating prostate cancer?

I. Davis, D. Bolton, J. Millar, 2013 .

The influence of the dwell time deviation constraint (DTDC) parameter on dosimetry with IPSA optimisation for HDR prostate brachytherapy

Ryan L. Smith, J. Millar, R. Franich, 2015, Australasian Physical & Engineering Sciences in Medicine.

Stereotactic radiosurgery for managing brain metastases in Victoria, 2012–2017

R. Milne, J. Ruben, J. Millar, 2020, The Medical journal of Australia.

MANAGEMENT OF MUSCLE‐INVASIVE BLADDER CANCER IN VICTORIA, 1990–1995

M. Frydenberg, J. Millar, V. Thursfield, 2006, ANZ journal of surgery.

The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy‐related infection over 5 years

J. Millar, A. C. Cheng, S. Evans, 2015, BJU international.

PV-0321: Influence of urethra contouring on NTCP models predicting urethral strictures in prostate HDRB

Ryan L. Smith, D. Joseph, J. Millar, 2018 .

In vivo characterization and numerical simulation of prostate properties for non‐thermal irreversible electroporation ablation

R. E. Neal, Ryan L. Smith, R. Davalos, 2014, The Prostate.

Interpolation to define clinical tumor stage in prostate cancer using clinical description of digital rectal examination

D. Murphy, I. Davis, J. Millar, 2018, Asia-Pacific journal of clinical oncology.

Men’s perceptions of prostate cancer diagnosis and care: insights from qualitative interviews in Victoria, Australia

K. Young, J. Fisher, M. Kirkman, 2017, BMC Cancer.

GPs' Insights into Prostate Cancer Diagnosis and Care in Regional Victoria, Australia

J. Fisher, M. Kirkman, R. Ruseckaite, 2016 .

Outcomes after PD-103 versus I-125 for Low Dose Rate Prostate Brachytherapy Monotherapy: An International, Multi-Institutional Study.

R. Stock, M. Keyes, J. Crook, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prospective evaluation of patient‐reported quality of life outcomes after external beam radiation treatment for prostate cancer in Victoria: A cohort study by the Victorian Prostate Cancer Registry

B. Billah, J. Millar, S. Evans, 2016, Journal of medical imaging and radiation oncology.

Rural residency and prostate cancer specific mortality: results from the Victorian Radical Prostatectomy Register

Damien Bolton, Nathan Lawrentschuk, Gianluca Severi, 2014, Australian and New Zealand journal of public health.